 |
|
|
 |
|
Priming Heart Before an Attack Could Limit Damage
|
 |  |  |  | Related Healthscout Videos |  |
|
Page: << Prev | 1 | 2 The American Journal of Physiology: Heart and Circulatory Physiology was expected to publish the study in its January issue.
Butler cautioned that the findings are preliminary. She said it is especially important for anyone experiencing ischemia, such as angina, to get medical treatment as soon as possible. "This is obviously investigational work not reproduced in humans," she explained. "I'm not saying stay home and take your nitro and aspirin, and have your angina, and you'll be fine. Immediate medical attention is still the standard of care for patients with heart disease."
"As far as scientific importance, this is a blockbuster," said Dr. Stephen Lahey, director of cardiac surgery at Maimonides Medical Center in New York City. He suggested that, if the findings are validated by further research, the delivery of the protective factors of the JAK-STAT pathway could be very useful in heart surgery.
Text Continues Below

For example, if a drug were developed based on the findings, it could be added to the solution that currently is used when stopping a heart during open heart surgery, which would buy more time for the surgeon to complete his work, Lahey explained. Heart surgeons are always operating on the "razor's edge" between having enough time to make needed repairs and the deadline for restarting a heart to prevent fatal damage, he noted.
"Maybe this will be an important arrow in the cardiac surgeon's quiver to protect your heart during surgery and transplants and angioplasty," Lahey said. He added that there is "a possibility this could have widespread use and have a great impact on preserving heart muscle." However, the concept would have to go through very rigorous testing for a long time before it would be in clinical use," Lahey added.
Dr. Roger Hajjar, director of the Cardiovascular Research Center at Mount Sinai Medical Center in New York City, felt the findings were more limited. He said the question is whether the preconditioning occurs "because of the heart or something in the blood that occurs after multiple ischemic attacks." There could be other pathways that also are activated, he said, and it may be there is a cumulative, protective effect from all of these pathways being activated.
More information
The American Heart Association has more on advances in heart disease research.
Page: << Prev | 1 | 2
|
Copyright © 2008 ScoutNews, LLC. All rights reserved.
Last updated 1/10/2008
|
 |

SOURCES: Karyn L. Butler, M.D., associate professor, surgery, division of trauma/critical care, University of Cincinnati; Roger Hajjar, M.D., director, Cardiovascular Research Center, Mount Sinai Medical Center, New York City; Stephen Lahey, M.D., professor, surgery, SUNY Downstate Medical Center, and division director, cardiothoracic surgery, Maimonides Medical Center, New York City; January 2008, American Journal of Physiology: Heart and Circulatory Physiology
|